At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Bupivacaine 0,5% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal
In Brief
A clinical study evaluating Bupivacaine 0,5% and NaCl 0,9% for Retinal Detachment. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The study aimed to investigate the effectivity of bupivacaine 0,5% as post-operative analgesia in intravitreal silicone evacutaion surgery
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRetinal Detachment
CountriesIndonesia
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
Primary CompletionOct 2016
Study CompletionDec 2016
First PostedFeb 2017
TodayJul 2026
First PostedFeb 8, 2017
Enrollment StartSep 1, 2016
Primary CompletionOct 1, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 9.4 years ago
Interventions
Bupivacaine 0,5%drug
Bupivacaine 0,5% was given on the subconjunctiva, in between stitches by the surgeon after finishing the last stitches
NaCl 0,9%drug
NaCl 0,9% was given on the subconjunctiva, in between stitches by the surgeon after finishing the last stitches